BRUKER CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Bruker Corporation
EquitiesBRKR
US1167941087
| Delayed Nasdaq Other stock markets | 5-day change | 1st Jan Change | ||
| 58.38 USD | +1.53% |  | +9.39% | -20.55% |
| 19/11 | Bruker Insider Bought Shares Worth $5,014,069, According to a Recent SEC Filing | MT |
| 19/11 | Bruker Corporation Presents at 6th Annual Wolfe Research Healthcare Conference 2024, Nov-19-2024 04:10 PM |
June 07, 2012 at 04:30 pm IST
Share
Bruker Corporation announced the appointment of Charles F. Wagner, Jr. as its executive vice president and new chief financial officer, effective on or about June 30, 2012. William J. Knight, the company's current CFO, will continue to serve as a member of the company's senior management team and will work with Mr. Wagner to ensure a smooth transition of his responsibilities as CFO. Since August 2010, Mr. Wagner has been a member of the company's board of directors and a member of the audit committee of the board, roles that he stepped down from effective June 4, 2012. Chris van Ingen, an independent director of the company, has been elected to serve on the audit committee as of June 4, 2012. Mr. Wagner most recently served as executive vice president of finance and administration and CFO of Progress Software Corporation, from November 2010 to March 2012.
Share
© S&P Capital IQ - 2012
Latest news about Bruker Corporation
| Bruker Insider Bought Shares Worth $5,014,069, According to a Recent SEC Filing | 20/11 | MT |
| Bruker Corporation Presents at 6th Annual Wolfe Research Healthcare Conference 2024, Nov-19-2024 04:10 PM | 20/11 | |
| Bruker Corporation Presents at Stifel 2024 Healthcare Conference, Nov-18-2024 08:35 AM | 18/11 | |
| Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development | 12/11 | CI |
| PriorNilsson Evolve Global increased 0.24 percent in October - three new holdings in healthcare | 08/11 | FW |
| Bruker Announces EpicIFTM, Fluorescence Signal Removal Technology, Transforming Cellscape Spatial Proteomics Platform | 08/11 | CI |
| Tranche Update on Bruker Corporation's Equity Buyback Plan announced on May 15, 2023. | 08/11 | CI |
| Sector Update: Health Care Stocks Advance Pre-Bell Tuesday | 05/11 | MT |
| Bruker Corporation, Q3 2024 Earnings Call, Nov 05, 2024 | 05/11 | |
| Bruker's Q3 Non-GAAP Earnings Fall, Revenue Rises; Lowers 2024 Outlook; Shares Decline | 05/11 | MT |
| Earnings Flash (BRKR) BRUKER CORPORATION Posts Q3 Revenue $864.4M | 05/11 | MT |
| Earnings Flash (BRKR) BRUKER CORPORATION Posts Q3 EPS $0.60 | 05/11 | MT |
| Bruker Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 | 05/11 | CI |
| Bruker Corporation Updates Earnings Guidance for the Fiscal Year 2024 | 05/11 | CI |
| Bruker's NanoString Unit Wins European Patent Lawsuit Against 10x Genomics | 17/10 | MT |
| Bruker Corporation Announces Formation of New Bruker Spatial Biology Division | 11/10 | CI |
| Bruker Corporation Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging | 07/10 | CI |
| Bruker Acquires Dynamic Biosensors | 02/10 | MT |
| Bruker Corporation acquired Dynamic Biosensors GmbH. | 02/10 | CI |
| Wolfe Research Downgrades Bruker to Peer Perform From Outperform | 30/09 | MT |
| Bruker Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-06-2024 10:00 AM | 06/09 | |
| Bruker Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM | 04/09 | |
| PrognomiQ, Inc. announced that it has received $34.315382 million in funding from Seer, Inc., Catalio Capital Management, LP, aMoon Fund, The Invus Group, LLC, Bruker Corporation and other investors | 26/08 | CI |
| Bruker Announces Successful Installation of 1.2 GHz Avance NMR Spectrometer at the Korea Basic Science Institute | 13/08 | CI |
| Tranche Update on Bruker Corporation's Equity Buyback Plan announced on May 15, 2023. | 10/08 | CI |
Chart Bruker Corporation
BRKR: Dynamic Chart
Company Profile
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. Its product lines include nCounter, CosMx, GeoMx and AtoMx. It also owns electron paramagnetic resonance (EPR) business.
Employees
9,707
Sector
Calendar
10/12/2024 - Nasdaq Investor Conference
More about the company
Income Statement and Estimates
More financial data
Ratings
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
58.38USD
Average target price
74.74USD
Spread / Average Target
+28.02%
Consensus
Profit revisions
Estimate revisions
Quarterly revenue - Rate of surprise
Company calendar
- Stock Market
- Equities
- BRKR Stock
- News Bruker Corporation
- Bruker Corporation Announces Management Changes
